结果：约半数孕妇和部分新生儿甲状腺功能增高，说明孕妇孕期抗甲状腺药物治疗不足。
Results: About half of the pregnant women with Graves' disease and part of newborn infants presented hyperthyroid status that ment the mothers have got inadequate antithyroid drug therapy.
甲亢患者经抗甲状腺药物治疗后，尿羟脯氨酸排出量逐步降低，至治疗后6个月，其排出量恢复正常，与对照组相比，P>0.05。
After using tapazol, the urinary hydroxyproline contents were gradually lowered and reached normal after a 6-month treatment, the difference between the two groups was insignificant by then (P>0.05).
本文报告甲亢经手术治疗者共178例，男31例，女147例。手术治疗主要用于抗甲状腺药物治疗半年左右而无明显疗效者，结节性甲状腺肿而续发甲亢者及高功能腺瘤。
Thyfoidectomy was performed on 178 patients of hyperthyroidism, men 31, women 147, they had been shown to be ineffective on medication of the antihyroide for about half a year.
目的探讨抗甲状腺药物(atd)引起粒细胞缺乏症的临床特点，治疗及转归。
Objective to investigate the clinical character, treatment and prognosis of agranulocytosis induced by anti-thyroid drug (ATD).
临床上使用抗甲状腺药物(atd)，控制甲亢症成为较常规定和治疗方法。
On clinical USES the anti-thyroid gland medicine (ATD), controls the armor high sickness to become compares the convention to decide with the method of treatment.
在接受抗甲状腺药物(atd)治疗的突眼性甲状腺肿615例患者中，215例(34.9%)发生毒性反应。
Out of 615 patients with Graves' disease who accepted the treatment of antithyroid drugs (ATD), 215 (34.9%) developed toxic effects of the drugs.
指出同位素治疗甲亢初期应服用抗甲状腺药物，讨论了淡漠型危象的有关问题。
We suggest that thyroid drugs should be given concurrently with radioactive iodine to treat early hyperthyroidism. The problems concerning apathetic thyroid crisis are also discussed.
抗甲状腺药物(atd)是治疗甲状腺功能亢进症主要手段，其不良反应备受学者们关注。
Antithyroid drugs (ATD) is the main treatment for hyperthyroidism and its adverse reactions have been much concerned by physicians.
抗甲状腺药物(atd)是治疗甲状腺功能亢进症主要手段，其不良反应备受学者们关注。
Antithyroid drugs (ATD) is the main treatment for hyperthyroidism and its adverse reactions have been much concerned by physicians.
应用推荐